Assembly Biosciences is a biotechnology company dedicated to the development of innovative small molecule antiviral therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Led by an accomplished team of leaders in virologic drug development, Assembly Bio is committed to improving outcomes for patients struggling with the serious, chronic impacts of herpesvirus, hepatitis B virus (HBV) and hepatitis delta virus (HDV) infections. For more information, visit assemblybio.com.
Assembly is headquartered in South San Francisco.
Company Details
- Employees
- 97
- Founded
- -
- Address
- 331 Oyster Point Blvd, South San Francisco,california 94080,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.assemblybio.com
- Keywords
- HBV Cure, Anti-Viral, Hepatitis B, Herpesvirus.
- HQ
- South San Francisco, California
Assembly Biosciences, Inc. Questions
Assembly Biosciences, Inc.'s website is http://www.assemblybio.com
Assembly Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/assembly-bio
Assembly Biosciences, Inc. has
97 employees.
View email and phone details for 97
employees at Assembly Biosciences, Inc..
Assembly Biosciences, Inc.'s industry is
Biotechnology Research
Assembly Biosciences, Inc.'s top competitors are
Bluejay Therapeutics,
Revolution Medicines,
Terns Pharmaceuticals,
Brii Biosciences,
Corcept Therapeutics,
Gilead Sciences,
Arcus Biosciences,
Akero Therapeutics,
Vera Therapeutics, Inc.,
Nurix Therapeutics.
Assembly Biosciences, Inc.'s categories are Biotechnology Research
Assembly Biosciences, Inc.'s founding year is 2014
